Evidence map›Paper›PMID 39402012›Full record

ArticleJournal of medical Internet research2024

Long-Term Efficacy of an AI-Based Health Coaching Mobile App in Slowing the Progression of Nondialysis-Dependent Chronic Kidney Disease: Retrospective Cohort Study.

Jianwei Ma, Jiangyuan Wang, Jiapei Ying, Shasha Xie, Qin Su, Tianmeng Zhou, Fuman Han, Jiayan Xu, Siyi Zhu, Chenyi Yuan and 4 more

Abstract read
In one paragraph

Article in Journal of medical Internet research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jianwei Ma *Department of Nephrology, The First Affiliated Hospital of Ningbo University, Ningbo, China.ORCID 0000-0002-9785-1770
Jiangyuan Wang *Beijing Kidney Health Technology Co., Ltd, Beijing, China.ORCID 0000-0002-4340-3040
Jiapei Ying *Department of Nephrology, The First Affiliated Hospital of Ningbo University, Ningbo, China.ORCID 0009-0005-9453-4138
Shasha Xie *Beijing Kidney Health Technology Co., Ltd, Beijing, China.ORCID 0009-0001-7808-4617
Qin SuDepartment of Nephrology, The First Affiliated Hospital of Ningbo University, Ningbo, China.ORCID 0009-0002-3834-8013
Tianmeng ZhouBeijing Kidney Health Technology Co., Ltd, Beijing, China.ORCID 0000-0003-3002-0929
Fuman HanBeijing Kidney Health Technology Co., Ltd, Beijing, China.ORCID 0009-0005-0903-8675
Jiayan XuHealth Science Center, Ningbo University, ningbo, China.ORCID 0009-0000-1472-0285
Siyi ZhuSchool of Public Health, Health Science Center, Ningbo University, Ningbo, China.ORCID 0009-0005-7246-3076
Chenyi YuanDepartment of Nephrology, The First Affiliated Hospital of Ningbo University, Ningbo, China.ORCID 0009-0005-9555-3541
Ziyuan HuangDepartment of Nephrology, The First Affiliated Hospital of Ningbo University, Ningbo, China.ORCID 0009-0004-6592-1166
Jingfang XuDepartment of Nephrology, The First Affiliated Hospital of Ningbo University, Ningbo, China.ORCID 0009-0006-9493-6978
Xuyong ChenBeijing Kidney Health Technology Co., Ltd, Beijing, China.ORCID 0000-0002-7131-2648
Xueyan BianDepartment of Nephrology, The First Affiliated Hospital of Ningbo University, Ningbo, China.ORCID 0000-0001-8242-0292

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic kidney disease (CKD) is a significant public health concern. Therefore, practical strategies for slowing CKD progression and improving patient outcomes are imperative. There is limited evidence to substantiate the efficacy of mobile app-based nursing systems for decelerating CKD progression.

objectiveThis study aimed to evaluate the long-term efficacy of the KidneyOnline intelligent care system in slowing the progression of nondialysis-dependent CKD.

methodsIn this retrospective study, the KidneyOnline app was used for patients with CKD in China who were registered between January 2017 and April 2023. Patients were divided into 2 groups: an intervention group using the app's nurse-led, patient-oriented management system and a conventional care group that did not use the app. Patients' uploaded health data were processed via deep learning optical character recognition, and the artificial intelligence (AI) system provided personalized health care plans and interventions. Conversely, the conventional care group received suggestions from nephrologists during regular visits without AI. Monitoring extended for an average duration of 2.1 (SD 1.4) years. The study's objective is to assess the app's effectiveness in preserving kidney function. The primary outcome was the estimated glomerular filtration rate slope over the follow-up period, and secondary outcomes included changes in albumin-to-creatinine ratio (ACR) and mean arterial pressure.

resultsA total of 12,297 eligible patients were enrolled for the analysis. Among them, 808 patients were successfully matched using 1:1 propensity score matching, resulting in 404 (50%) patients in the KidneyOnline care system group and another 404 (50%) patients in the conventional care group. The estimated glomerular filtration rate slope in the KidneyOnline care group was significantly lower than that in the conventional care group (odds ratio -1.3, 95% CI -2.4 to -0.1 mL/min/1.73 m

conclusionsThe utilization of KidneyOnline, an AI-based, nurse-led, patient-centered care system, may be beneficial in slowing the progression of nondialysis-dependent CKD.

Indexed as

Artificial IntelligenceDisease ProgressionMobile ApplicationsRenal Insufficiency, ChronicAdultAgedChinaFemaleGlomerular Filtration RateHumansMaleMentoringMiddle AgedRetrospective Studiesappartificial intelligencechronic kidney diseaseCKDeHealth carehealth coachingkidney functionmobile appmobile phoneself-managementtelemedicine

Identifiers

PMID39402012
PMCPMC11629034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.